Yıl: 2020 Cilt: 23 Sayı: 1 Sayfa Aralığı: 108 - 117 Metin Dili: İngilizce DOI: 10.31086/tjgeri.2020.144 İndeks Tarihi: 03-11-2020

EVALUATION OF DIGOXIN LEVELS IN ELDERLY PATIENTS IN A TRAINING HOSPITAL: AN 11-YEAR FOLLOW-UP

Öz:
Introduction: Digoxin monitoring is important in the elderly because of thetoxicity risk. The aim of this study was to evaluate the orders made by different unitsfor digoxin monitoring in the elderly.Materials and Method: Digoxin orders and results in patients aged over 65,patients’ demographic characteristics, such as age and gender, the unit from whichthe order was made, and patients’ pre-diagnoses were retrospectively recorded.Patients were divided into young-old, middle-old, and very-old groups, and theresults were divided into subtherapeutic, therapeutic, and toxic levels.Results: The percentage of young-old, middle-old, and very-old patients was39.4%, 45.3%, and 15.3%, respectively. Women were more (64.3%) and their medianage and digoxin concentrations were higher (p<0.001). Outpatients’ mediandigoxin concentrations were lower than inpatients’ median digoxin concentrations(p<0.001). A proportion of 46.6% of all digoxin levels were therapeutic; 29.2% weresubtherapeutic; and 24.2% were toxic. Subtherapeutic levels in males and toxiclevels in females predominated (p<0.001). Toxic levels were higher in inpatients,and subtherapeutic levels were higher in outpatients (p<0.001). The highest rateof therapeutic levels was observed in young-old patients (48.7%), while toxic levelswere observed most frequently in very-old patients (28.1%). The highest numberof digoxin orders in elderly patients was from the emergency department (44.2%).Conclusion: In elderly patients, more than half of the serum digoxin orders wereinappropriate. These results significantly changed according to gender, outpatientor inpatient status, age, and the ordering unit. Changes in digoxin pharmacokinetics,especially in the geriatric period, require physicians to be vigilant of subtherapeuticdrug concentrations.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Cheng JW, Rybak I. Use of digoxin for heart failure and atrial fibrillation in elderly patients. Am J Geriatr Pharmacother 2010;8(5):419-27. (PMID:21335295).
  • 2. Ilerigelen B. Heart failure in elderly. Turkish Journal of Geriatrics 2010;13(Supplement 2):21-32. (in Turkish).
  • 3. Meibohm B, Beierle I, Derendorf H. How important are gender differences in pharmacokinetics? Clin Pharmacokinet 2002;41(5):329-42. (PMID:12036391).
  • 4. Puche Canas E, Aomar Millan I, Carrillo Santos JC. Inappropriate blood levels of digoxin in a study of 2,849 patients from a teaching hospital: the influence of age and sex. An Med Interna 2004;21(12):581-4. (PMID:15628952).
  • 5. Ahmed A. Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations. J Gerontol A Biol Sci Med Sci 2007;62(3):323-9. (PMID:17389731).
  • 6. Kang JS, Lee MH. Overview of therapeutic drug monitoring. Korean J Intern Med 2009;24(1):1-10. (PMID:19270474).
  • 7. Currie GM, Wheat JM, Kiat H. Pharmacokinetic considerations for digoxin in older people. Open Cardiovasc Med J 2011;5:130-5. (PMID:21769303).
  • 8. Miura T, Kojima R, Sugiura Y, Mizutani M, Takatsu F, Suzuki Y. Effect of aging on the incidence of digoxin toxicity. Ann Pharmacother 2000;34(4):427-32. (PMID:10772425).
  • 9. Hafner JW Jr, Belknap SM, Squillante MD, Bucheit KA. Adverse drug events in emergency department patients. Ann Emerg Med 2002;39(3):258-67. (PMID:11867978).
  • 10. Budnitz DS, Shehab N, Kegler SR, Richards CL. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007;147(11):755-65. (PMID:18056659).
  • 11. Bernard DW, Bowman RL, Grimm FA, Wolf BA, Simson MB, Shaw LM. Nighttime dosing assures postdistribution sampling for therapeutic drug monitoring of digoxin. Clin Chem 1996;42(1):45-9. (PMID:8565231).
  • 12. Ozturk Z, Cuhadar S. Evaluation and clinical significance of factors affecting the serum digoxin levels in patients taking digoxin. Bezmialem Science 2018;6:31-6. (in Turkish).
  • 13. Sillars A, Ho FK, Pell GP, et al. Sex differences in the association of risk factors for heart failure incidence and mortality. Heart 2020;106(3):203-12. (PMID:31366573).
  • 14. Garcia-Iranzo EM, Rodriguez-Lucena FJ, Matoses- Chirivella C, Garcia-Monsalve A, Murcia-Lopez AC, Navarro-Ruiz A. Pharmacokinetic monitoring of chronic treatment with digoxin from primary health care. Farm Hosp 2017;41(4):527-32. (PMID:28683704).
  • 15. Mordasini MR, Krahenbuhl S, Schlienger RG. Appropriateness of digoxin level monitoring. Swiss Med Wkly 2002;132(35-36):506-12. (PMID:12506332).
  • 16. Dalaklioglu S. Evaluating appropriateness of digoxin, carbamazepine, valproic acid, and phenytoin usage by therapeutic drug monitoring. Clin Lab 2013;59(3- 4):325-31. (PMID:23724621).
  • 17. Limon G, Ersoy G, Oray NC, Bayram B, Limon O. Retrospective evaluation of patients with elevated digoxin levels at an emergency department. Turk J Emerg Med 2016;16(1):17-21. (PMID:27239633).
  • 18. Orrico KB, Wu M, Wilson AR. Assessment of the appropriateness of serum digoxin concentration measurement in a medical group setting. J Manag Care Pharm 2011;17(9):695-700. (PMID:22050394).
  • 19. Grzesk G, Stolarek W, Kasprzak M, et al. Therapeutic drug monitoring of digoxin-20 years of experience. Pharmacol Rep 2018;70(1):184-9. (PMID:29414149).
  • 20. Gerede DM, Koboev R, Caglar N, Kilickap M, Erol C. Evaluation and clinical significance of factors affecting the serum digoxin levels in patients taking digoxin. MN Cardiology 2015;22(1):30-6. (in Turkish).
  • 21. Oncu S, Gelal A, Aslan O, Ucku RS. Appropriateness of digoxin measurement in hospitalized patients. Biochem Med (Zagreb) 2018;28(1):010901. (PMID:29187799).
  • 22. Oncu S, Baskurt A, Senturk B, Aslan O, Kume T, Ucku R, Gelal A. Educational intervention to improve appropriate digoxin therapeutic drug monitoring: a quasi-experimental study. Eur J Hosp Pharm 2019;0:1- 5.
  • 23. Akan P, Erdincler D, Tezcan V, Beger T. Drug use in the elderly. Turkish Journal of Geriatrics 1999;2:33-8. (in Turkish).
  • 24. Mundet X, Vidal X, Arnau JM. The characteristics of digoxin utilization in a population under emergency care for heart failure or auricular fibrillation. Med Clin (Barc) 1993;100(3):94-7. (PMID:8426500).
  • 25. Al Za’abi M, Al Muqbali J, Al-Waili K. Sampling time and indications appropriateness for therapeutically monitored drugs at a teaching university hospital in Oman. Saudi Pharm J 2015;23(4):458-62. (PMID:27134551).
APA TAPTIK İ, bilgili s, Bozkaya G (2020). EVALUATION OF DIGOXIN LEVELS IN ELDERLY PATIENTS IN A TRAINING HOSPITAL: AN 11-YEAR FOLLOW-UP. , 108 - 117. 10.31086/tjgeri.2020.144
Chicago TAPTIK İsmail Yılmaz,bilgili sibel,Bozkaya Giray EVALUATION OF DIGOXIN LEVELS IN ELDERLY PATIENTS IN A TRAINING HOSPITAL: AN 11-YEAR FOLLOW-UP. (2020): 108 - 117. 10.31086/tjgeri.2020.144
MLA TAPTIK İsmail Yılmaz,bilgili sibel,Bozkaya Giray EVALUATION OF DIGOXIN LEVELS IN ELDERLY PATIENTS IN A TRAINING HOSPITAL: AN 11-YEAR FOLLOW-UP. , 2020, ss.108 - 117. 10.31086/tjgeri.2020.144
AMA TAPTIK İ,bilgili s,Bozkaya G EVALUATION OF DIGOXIN LEVELS IN ELDERLY PATIENTS IN A TRAINING HOSPITAL: AN 11-YEAR FOLLOW-UP. . 2020; 108 - 117. 10.31086/tjgeri.2020.144
Vancouver TAPTIK İ,bilgili s,Bozkaya G EVALUATION OF DIGOXIN LEVELS IN ELDERLY PATIENTS IN A TRAINING HOSPITAL: AN 11-YEAR FOLLOW-UP. . 2020; 108 - 117. 10.31086/tjgeri.2020.144
IEEE TAPTIK İ,bilgili s,Bozkaya G "EVALUATION OF DIGOXIN LEVELS IN ELDERLY PATIENTS IN A TRAINING HOSPITAL: AN 11-YEAR FOLLOW-UP." , ss.108 - 117, 2020. 10.31086/tjgeri.2020.144
ISNAD TAPTIK, İsmail Yılmaz vd. "EVALUATION OF DIGOXIN LEVELS IN ELDERLY PATIENTS IN A TRAINING HOSPITAL: AN 11-YEAR FOLLOW-UP". (2020), 108-117. https://doi.org/10.31086/tjgeri.2020.144
APA TAPTIK İ, bilgili s, Bozkaya G (2020). EVALUATION OF DIGOXIN LEVELS IN ELDERLY PATIENTS IN A TRAINING HOSPITAL: AN 11-YEAR FOLLOW-UP. Türk Geriatri Dergisi, 23(1), 108 - 117. 10.31086/tjgeri.2020.144
Chicago TAPTIK İsmail Yılmaz,bilgili sibel,Bozkaya Giray EVALUATION OF DIGOXIN LEVELS IN ELDERLY PATIENTS IN A TRAINING HOSPITAL: AN 11-YEAR FOLLOW-UP. Türk Geriatri Dergisi 23, no.1 (2020): 108 - 117. 10.31086/tjgeri.2020.144
MLA TAPTIK İsmail Yılmaz,bilgili sibel,Bozkaya Giray EVALUATION OF DIGOXIN LEVELS IN ELDERLY PATIENTS IN A TRAINING HOSPITAL: AN 11-YEAR FOLLOW-UP. Türk Geriatri Dergisi, vol.23, no.1, 2020, ss.108 - 117. 10.31086/tjgeri.2020.144
AMA TAPTIK İ,bilgili s,Bozkaya G EVALUATION OF DIGOXIN LEVELS IN ELDERLY PATIENTS IN A TRAINING HOSPITAL: AN 11-YEAR FOLLOW-UP. Türk Geriatri Dergisi. 2020; 23(1): 108 - 117. 10.31086/tjgeri.2020.144
Vancouver TAPTIK İ,bilgili s,Bozkaya G EVALUATION OF DIGOXIN LEVELS IN ELDERLY PATIENTS IN A TRAINING HOSPITAL: AN 11-YEAR FOLLOW-UP. Türk Geriatri Dergisi. 2020; 23(1): 108 - 117. 10.31086/tjgeri.2020.144
IEEE TAPTIK İ,bilgili s,Bozkaya G "EVALUATION OF DIGOXIN LEVELS IN ELDERLY PATIENTS IN A TRAINING HOSPITAL: AN 11-YEAR FOLLOW-UP." Türk Geriatri Dergisi, 23, ss.108 - 117, 2020. 10.31086/tjgeri.2020.144
ISNAD TAPTIK, İsmail Yılmaz vd. "EVALUATION OF DIGOXIN LEVELS IN ELDERLY PATIENTS IN A TRAINING HOSPITAL: AN 11-YEAR FOLLOW-UP". Türk Geriatri Dergisi 23/1 (2020), 108-117. https://doi.org/10.31086/tjgeri.2020.144